Breaking barriers in rare disease research: a pilot trial of thromboprophylaxis with apixaban versus aspirin in JAK2-Positive myeloproliferative neoplasms.
Not available.
Authors
Kimpton Kimpton, Cerquozzi Cerquozzi, Toupin Toupin, Ianotto Ianotto, Villleneuve Villleneuve, Siegal Siegal, Carrier Carrier, Delluc Delluc
View on Pubmed